Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on May 12, 2025

Foreign Investment Network Announces FIN-Web Conference & AI Expo 2025 in Silicon Valley
SILICON VALLEY, CA, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- The Foreign Investment Network (FIN), a leading London-based global investment consulting and publishing company, is proud to announce the upcoming FIN-Web Conference …

Softstack Completes Smart‑Contract Audit of Fetch AI’s Agentverse Launchpad, and Eliminates Risks
Softstack audits Fetch AI’s Agentverse launchpad, fixes key risks, and strengthens security for tokenized AI agents and bonding-curve sales. FLENSBURG, SCHLESWIG-HOLSTEIN, GERMANY, May 12, 2025 /EINPresswire.com/ -- Softstack, a leading Web3 security …

Innovorbs Technologies Expands Operations with Premium 24/7 Managed Services and Strategic Staff Augmentation
Innovorbs Technologies announces expanded 24/7 managed IT services and staff augmentation for global businesses seeking resilience and operational excellence. HOUSTON, TX, UNITED STATES, May 12, 2025 /EINPresswire.com/ -- Innovorbs Technologies, …

Mentaily Raises $3M in Seed Funding to Transform Psychiatric Intervention Through AI-Powered Diagnosis and Support
GenAI Platform LIV Delivers Personal and Accurate Mental Health Response, Expanding the Pipeline of Pioneering Technologies from ARC at Sheba Medical Center RAMAT GAN, ISRAEL, May 12, 2025 /EINPresswire.com/ -- Mentaily, the creator of AI-powered …

Interim Financial Results
PERTH, Australia, May 12, 2025 (GLOBE NEWSWIRE) -- Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (“Paladin” or the “Company”) advises that it has released its unaudited condensed interim financial report and management discussion and analysis (MD…

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ
PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright …

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering
Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …

Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2025 and Declares Quarterly Dividend
TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the first quarter ended March 31, 2025 and declared a $1.00 per share dividend payable on July 11, …

Microvast Reports First Quarter 2025 Financial Results
Record company Q1 revenue, increased 43.2% year over year to $116.5 million Gross margin increased from 21.2% to 36.9%, a 15.7 percentage point improvement year over year STAFFORD, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: …

3D Systems Reports First Quarter 2025 Financial Results
ROCK HILL, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2025. Revenue of $95 million as growth in new hardware systems and related services was offset …

AirJoule Technologies Announces First Quarter 2025 Results
RONAN, Mont., May 12, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), the developer of the transformational AirJoule® system for separating pure water from air, today announced its first …

New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism
COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) continued to provide …

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context …

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update
Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapy SEED’s first‑in‑class RBM39 degrader, reported at AACR 2025 for its total tumor regression data in …

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights
FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced positive topline results from Phase 1 study of TNX- …

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq
MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and …

Satellogic Secures Multi-Million Dollar Agreement with Asia Pacific Customer
DAVIDSON, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in high-resolution Earth observation data, announced today it has entered into a multi-million dollar agreement with an Asia Pacific customer. The agreement provides …

Cellectis Reports Financial Results for the First Quarter 2025
Lasme-cel (UCART22) Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025 Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r NHL) ongoing with readout expected in late 2025 …

Editas Medicine Announces First Quarter 2025 Results and Business Updates
Company to share in vivo preclinical data demonstrating the successful use of targeted lipid nanoparticles to deliver HBG1/2 promoter editing cargo to hematopoietic stem and progenitor cells (HSPCs) at ASGCT this week Company will also share in vivo …

Life360 Reports Record Q1 2025 Results
Monthly Active Users Reached Approximately 83.7 million Record Q1 Global Net Additions to Paying Circles of 137 thousand - Reaching 2.4 million Total Total Quarterly Revenue Grew 32% Year-Over-Year to $103.6 million Annualized Monthly Revenue increased 38% …